You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Details for New Drug Application (NDA): 022007


✉ Email this page to a colleague

« Back to Dashboard


NDA 022007 describes PERFOROMIST, which is a drug marketed by Mylan Speclt and is included in one NDA. It is available from two suppliers. Additional details are available on the PERFOROMIST profile page.

The generic ingredient in PERFOROMIST is formoterol fumarate. There are nineteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the formoterol fumarate profile page.
Summary for 022007
Tradename:PERFOROMIST
Applicant:Mylan Speclt
Ingredient:formoterol fumarate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 022007
Mechanism of ActionAdrenergic beta2-Agonists
Medical Subject Heading (MeSH) Categories for 022007
Suppliers and Packaging for NDA: 022007
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PERFOROMIST formoterol fumarate SOLUTION;INHALATION 022007 NDA AUTHORIZED GENERIC Mylan Pharmaceuticals Inc. 0378-1631 0378-1631-91 60 POUCH in 1 CARTON (0378-1631-91) / 1 VIAL in 1 POUCH / 2 mL in 1 VIAL
PERFOROMIST formoterol fumarate SOLUTION;INHALATION 022007 NDA AUTHORIZED GENERIC Mylan Pharmaceuticals Inc. 0378-1631 0378-1631-93 30 POUCH in 1 CARTON (0378-1631-93) / 1 VIAL in 1 POUCH (0378-1631-32) / 2 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INHALATIONStrength0.02MG/2ML
Approval Date:May 11, 2007TE:ANRLD:Yes

Expired US Patents for NDA 022007

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speclt PERFOROMIST formoterol fumarate SOLUTION;INHALATION 022007-001 May 11, 2007 ⤷  Try a Trial ⤷  Try a Trial
Mylan Speclt PERFOROMIST formoterol fumarate SOLUTION;INHALATION 022007-001 May 11, 2007 ⤷  Try a Trial ⤷  Try a Trial
Mylan Speclt PERFOROMIST formoterol fumarate SOLUTION;INHALATION 022007-001 May 11, 2007 ⤷  Try a Trial ⤷  Try a Trial
Mylan Speclt PERFOROMIST formoterol fumarate SOLUTION;INHALATION 022007-001 May 11, 2007 ⤷  Try a Trial ⤷  Try a Trial
Mylan Speclt PERFOROMIST formoterol fumarate SOLUTION;INHALATION 022007-001 May 11, 2007 ⤷  Try a Trial ⤷  Try a Trial
Mylan Speclt PERFOROMIST formoterol fumarate SOLUTION;INHALATION 022007-001 May 11, 2007 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.